Unclaimed rewards returned to you
Support | 415-386-8600
Deliver approved patient stipends, visit reimbursements, and participation payments with less delay and less administrative friction. TruCentive gives sponsors and sites flexible delivery, participant choice, claim-aware reminders, and transparent reconciliation.
No credit card required. Build and send de-identified payment samples before you commit.
Fair compensation recognizes time and burden; reimbursement restores reasonable participation-related expenses. FDA guidance says payment should be just and fair, reviewed by the IRB, described in informed consent, and accrued as the study progresses—not held hostage to completion. A sound operating system makes that approved plan easier for participants and research teams to follow.
TruCentive offers 1M+ gift card, merchandise, payment, prepaid, and other options for recipient choice.
FDA payment and reimbursement guidance · OHRP informed-consent guidance · NCBI evidence review of trial financial stress · Reimbursement and retention study. Research findings are context-specific and not guaranteed outcomes.
For a participant, parking, fuel, meals, childcare, connectivity, or time away from work can determine whether a visit is feasible. Even a modest approved payment can acknowledge burden or restore a cost that would otherwise fall on the participant.
Reimbursement can cover reasonable expenses such as airfare, parking, lodging, mileage, meals, or other approved costs. FDA states that reasonable travel reimbursement does not, by itself, raise undue-influence concerns.
Stipends or compensation recognize time, effort, inconvenience, and burden. Amounts should be just, fair, proportionate, and reviewed for the specific protocol and population.
Credit should accrue as visits or activities occur. Prorated or milestone-based payments protect the right to withdraw and avoid making the entire amount contingent on completion.
Where the approved plan allows it, offer payment methods that fit participants’ location, access needs, and preferences. Choice should improve usability—not change the study’s risk-benefit assessment.
Standardize controls and reconciliation while preserving each protocol’s approved amounts, eligible expenses, visit schedule, withdrawal treatment, payment methods, privacy model, and consent language.
Deliver approved compensation after scheduled site visits, procedures, interviews, or assessments without maintaining manual gift-card inventories.
Reimburse approved mileage, airfare, parking, lodging, meals, or other expenses according to sponsor, site, and protocol rules.
Handle approved screening-related expenses or payments consistently, including the documented treatment of screen failures and pre-enrollment travel.
Trigger prorated payments after approved visits, phases, diaries, questionnaires, or other protocol milestones instead of waiting for study completion.
Support telehealth visits, ePRO completion, remote interviews, decentralized assessments, and connectivity-related reimbursement where approved.
Maintain consistent payment and reminder workflows for extension studies, follow-up assessments, registries, and long-duration participation.
TruCentive combines participant choice with the controls sponsors, CROs, sites, Finance, Procurement, Security, Privacy, and Compliance expect. Build reusable projects, use subject IDs, deliver through multiple channels, automate reminders, and track the who, what, and when of approved payments.
Offer gift cards, direct-payment methods, prepaid options, merchandise, or a curated selection where the approved payment plan permits participant choice.
Support international programs with country-specific options and local merchants. Product availability does not replace local ethics, tax, sanctions, currency, labor, or regulatory review.
Send by email, SMS, both, printed links, or bulk links. Automated reminders stop after claim; post-claim messages can confirm receipt or provide approved next steps.
Use subject IDs and data-minimization practices, monitor delivery and claim status, and apply roles and controls. TruCentive describes a HIPAA de-identification capability; each covered entity must validate its own HIPAA obligations, configuration, and agreements.
Unused payment value
May be trapped in purchased cards, retained as provider breakage, or difficult to return to the protocol budget.
Returned to your TruCentive account under Pay as You Go.
Participant options
One card type, physical inventories, or separate vendors by country.
1M+ gift card, payment, prepaid, merchandise, and other options.
Payment operations
Manual purchasing, code inventories, spreadsheets, and one-off participant emails.
Reusable projects, individual or list-based sends, email/SMS, printed delivery, and bulk links.
Visit follow-through
One payment message with manual resend and support work.
Claim-aware reminders, resend or revoke controls, and approved post-claim communication.
Privacy and reconciliation
Payment operations may expose excess identifiers and provide limited closeout visibility.
Subject-ID workflows, roles and controls, claim tracking, reporting, and unclaimed-value visibility.
TruCentive reports 20.5% of clinical-trial compensation went unclaimed in 2022 and reports 31.9% unclaimed across digital incentives in 2025. It says most Pay as You Go customers save 23% after fees. Verify the methodology and current figures before publication; results depend on protocol, payment amount, timing, population, delivery method, and claim period.
Define reimbursement, compensation, appreciation, and any completion component separately. Document amounts, purpose, schedule, proration, withdrawal treatment, eligible expenses, payment methods, tax handling, and approval requirements for each population and country.
Map every approved visit, activity, expense, and payment milestone. Configure eligibility, recipient identifiers, delivery channels, reminders, expiration, resend or revoke authority, and exception handling.
Deliver only after the applicable approved event or expense verification. Use the minimum participant information necessary and keep clinical data out of the payment workflow wherever possible.
Monitor delivery, claims, failed messages, duplicates, exceptions, partial participation, and unclaimed value. Reconcile against the protocol budget and approved payment schedule without exposing unnecessary clinical information.
Reimbursement restores reasonable participation-related expenses. A stipend or compensation recognizes time, effort, inconvenience, or burden. Consent materials and payment records should describe each accurately.
FDA says the IRB should review the amount, method, and timing of payment for fairness and undue influence. The consent document should state all payment information, including the schedule and applicable conditions.
Payment should accrue as participation progresses and should not be wholly contingent on study completion. The approved plan should explain partial payment, timing, and what happens if the investigator removes a participant.
FDA does not consider reimbursement for reasonable travel expenses—such as airfare, parking, and lodging—to raise undue-influence concerns by itself. The protocol and IRB still determine what is reasonable and approved.
Minimize identifiers, use approved subject IDs, apply role-based access, and keep clinical information separate from payment operations. HIPAA de-identification requires either Safe Harbor or Expert Determination; risk is reduced, not necessarily zero.
One platform can support multi-country delivery, but the approved amount, method, tax treatment, currency, sanctions screening, privacy terms, consent language, and ethics requirements must be validated for every jurisdiction and site.
Bring one protocol payment schedule to a TruCentive design session. Leave with a branded sample, mapped visit and reimbursement workflow, and a clearer approach to participant delivery and closeout.
1M+ options · International coverage · Email, SMS & bulk links · Subject-ID workflows · Unclaimed value returned with Pay as You Go